No Detail Found!

Comparison of efficacy and tolerability of iron polymaltose complex with ferrous sulphate in treatment of children with iron deficiency anemia

Author(s)
Saba Bakht Department of Pediatrics, Service Institute of Medical Sciences, Lahore, Fazaia Medical College, Medicsi Hospital, CMH, Bahria University, Karachi and Clarence Town Medical Practice, NSW, Australia
Madeeha Ikram Department of Pediatrics, Service Institute of Medical Sciences, Lahore, Fazaia Medical College, Medicsi Hospital, CMH, Bahria University, Karachi and Clarence Town Medical Practice, NSW, Australia
Syeda Sadaf Shirazi Department of Pediatrics, Service Institute of Medical Sciences, Lahore, Fazaia Medical College, Medicsi Hospital, CMH, Bahria University, Karachi and Clarence Town Medical Practice, NSW, Australia
Osman Bin Saif Department of Pediatrics, Service Institute of Medical Sciences, Lahore, Fazaia Medical College, Medicsi Hospital, CMH, Bahria University, Karachi and Clarence Town Medical Practice, NSW, Australia
Fazal-ur-Rehman Department of Pediatrics, Service Institute of Medical Sciences, Lahore, Fazaia Medical College, Medicsi Hospital, CMH, Bahria University, Karachi and Clarence Town Medical Practice, NSW, Australia
Aimen Saif Department of Pediatrics, Service Institute of Medical Sciences, Lahore, Fazaia Medical College, Medicsi Hospital, CMH, Bahria University, Karachi and Clarence Town Medical Practice, NSW, Australia
Abstract
Objective: To compare ferrous sulphate and iron polymaltose complex in terms of mean change in hemoglobin and frequency of complications in treatment of iron deficiency anemia (IDA) in children. Methodology: This Randomized control trial was done at department of pediatrics KRL hospital Islamabad from June 2017 to November 2017. Children with IDA, 6-12 years of age with hemoglobin level less than 10 mg/dl were enrolled and admitted in ward. Two groups were formed; patients in Group A were administered ferrous sulphate and Group B iron polymaltose complex. Patients in each group were supervised with iron 6mg per kg per day, for a period of one month. Blood samples were taken at the start and end of one month of iron therapy completion to measure hemoglobin levels along with the complications. Results: The study included 148 cases; 74 in each group. Mean age among group A was 8.93 ± 1.93 and for group B was 8.35 ± 1.88 years. Frequency of male and female sample population was 43.24% and 56.76% in Group-A while and 50% and 50% in Group-B. Mean change in hemoglobin was 1.35 ± 0.80 in Group-A and 0.90 ± 1.00 in Group-B, (p = 0.003) showing a significant difference in hemoglobin after one month of therapy. Likewise, mean change for ferritin level before and after one month, was 1.62 ± 0.63 in Group-A and 0.82 ± 1.06 in Group-B (p = 0.000). Conclusion: On comparison of ferrous sulphate and iron polymaltose complex in terms of mean change in hemoglobin and frequency of complications in treatment of IDA in children, ferrous sulphate was found to be significantly convalescent than iron polymaltose complex.
Publication Details
Page(s) 608-611
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 47, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
ferrous sulphate, Iron deficiency anaemia, iron polymaltose complex, mean change
0

Citations

0

Downloads

45

Views